MD Conference Express AHA 2011 - (Page 5)

Features PEER-REVIEWED HIGHLIGHTS FROM THE The European Society of Cardiology 2008 Annual Meeting Munich, Germany August 30—September 4, 2008 Robert P Giugliano, MD, SM . Brigham and Women’s Hospital, USA Jacob A. Udell, MD, MPH Brigham and Women's Hospital, USA 6 8 Harnessing Genetics to Improve CV Care Personalized Cardiovascular Medicine and Drug Development - Time for a New Paradigm Clinical Trial Highlights Peer-Reviewed CARDIOLOGY THE OFFICIAL PEER-REVIEWED HIGHLIGHTS FROM Clinical Trial Highlights Translational Research LEAD CARDIOLOGY ADVISORS Elliott Antman, MD, FAHA Scientific Sessions Program Chair American Heart Association 10 Rivaroxaban Improves Outcomes in Patients with Acute Coronary Syndromes 11 Escalating Clopidogrel by Involving a Genetic Strategy-TIMI 56 12 Results from the PALLAS Study 12 Extended Apixaban Failed to Reduce VTE Risk in Medically Ill Patients 13 Results from the TRA•CER Trial 14 Results from the ISAR-REACT 4 Trial 15 CETP Inhibitor Evacetrapib Reduces LDL-C and Raises HDL-C Levels 16 AIM-HIGH: Niacin Provides No Added Benefit for Statin Users With Well-Controlled LDL 17 Free Post-MI Medications Improve Adherence Without Added Costs 19 C-PORT E: Elective PCI Safe in Hospitals with No Cardiac Surgery Support Therapeutic Updates 20 Atrial Fibrillation 22 Valvular Disease 24 Surgical Interventions 26 Imaging 28 Peripheral Arterial Diasese Other News 30 The PARTNER Trial: A new Paradigm for Treating Valvular Heart Disease 31 Prevention Guidelines in Women Broaden the Definition of CV Risk 32 New Revascularization Guidelines Focus on Collaborative Care Therapeutic Updates November 12 - 16, 2011 Orlando, Florida, USA scientificsessions.org my.americanheart.org Harnessing Genetics to Improve Cardiovascular Care The Paul Dudley White International Lecture was presented by Hugh C Watkins, MD, Oxford, United Kingdom. Prof. Watkins argued that the impact of genetics will grow and become a valuable tool for predicting efficacy, as well as aid in the development of treatments for individuals at risk of developing cardiovascular disease. See Page 6. Distribution of this independent report is supported by Marc P. Bonaca, MD, MPH INTERNATIONAL MEDICAL ADVISORY BOARD Brigham and Women's Hospital, USA Olakunle O. Akinboboye, MD Roberto R. Giraldez, MD INTERNATIONAL MEDICAL ADVISORY BOARD New York Hospital Queens Heart Institute - Hospital das Philip E. Aylward, BM BCh, PhD Milan Luknar, MD Clinicas Martin J. Abrahamson, MD Flinders Medical Centre, Australia NationalC. Messineo, MD Frank Institute of Cardiovascular Beth Israel Deaconess Disease, Slovak Republic Edmund Chada Baracat, MD Medical Center New York Hospital Queens Raymond Massay, MD ScientificDiabetes Center Director, Joslin Tore Kvien, MD President, Brazilian Medical Association Heinz Burgmann, MD Diakonhjemmet Hospital, Caribbean Cardiac Society Jeroen J. Bax,Vienna Past-President, EULAR University of MD, PhD Elizabeth Mayer-Davis, PhD Leiden University Medical Center Michel E. Nussbaum, Harold J. Burstein, MD, PhD President, Health Care & Education, The Netherlands MD, FACP American Diabetes Association Dana-Farber Cancer Insitute Ramon Corbalán, MD New York Hospital Queens Toyoaki Murohara, MD, PhD Daniel J. DeAngelo, MD, PhD Pontificia Universidad Católica, Chile Patrick Ying, MD Nagoya University, Japan Dana-Farber Cancer Institute Anthony J. Dalby MB, ChB, FCP NYU Medical Center Ernesto Paolasso, MD Gary W. Falk, MD, MS Milpark Hospital, South Africa Joanna J. Wykrzykowska, MD Instituto de Investigaciones Cleveland Clinic Jean-Pierre Després, PhD Beth Israel Deaconess Clínicas de Rosario, Argentina Apostolos Georgopoulos, MD Medical Center Université Laval, Canada Anne L. Peters, MD, FACP CDE , University of Vienna Vivian A. Fonseca, MD, FRCP Univ. of Southern California, USA Robert P Giugliano, MD, SM . Tulane University, USA Fausto Pinto, MD Brigham & Women’s Hospital Timothy J. Gardner, MD CPC Chair, European Society of Christiana Care Center for Cardiology Congress 2009-2010 Heart & Vascular Health, USA Hiroaki Shimokawa, MD, PhD Eva Gonçalvesova, MD, PhD Editor-in Chief, EDITORIAL STAFF President, Japanese Circulation Journal Publisher Slovak Society of Cardiology Jennifer Goodwin Andrew F. Stewart, MD Vice President, Beth Johnson Robert R. Henry, MD Past-Chair, ADA Scientific Sessions Publishing President, Medicine & Science, Chuwa Tei, MD Associate Director, American Diabetes Association Heather Q. Sinclair President of the Japanese College Publishing of Cardiology Production Assistant Lauren Valone Neil Canavan Medical Writers STAFF MedCom Depot President Jennifer Goodwin Design IntuitDesign Vice President, Beth Johnson Publishing Production Manager Lauren Valone SALES Rita Buckley Medical Writers Jennifer Goodwin Tel.: +1-617-515-9797 Anne Jacobson Maria Vinall ALSO IN THIS ISSUE • Strategies for Complex Valvular Disease • Clinical Trial Highlights – The Science Behind Cardiology • New Transcatheter Valve Technologies and Techniques PUBLISHER 98 Oxford Street Suite #1 Arlington, MA 02474 USA Tel.: +1-617-515-9797 E-mail: reports [at] goodwingroupintl.com BUSINESS DEVELOPMENT Jennifer Goodwin Tel.: +1-617-515-9797 www.mdconferencexpress.com reports [at] goodwingroupintl.com +1-617-515-9797 The publisher does not assume any legal liability or responsibility for the accuracy, completeness, or usefulness of the information supplied herein, nor for any opinion expressed. The publisher, its agents, and employees will not be liable for any loss or damage arising directly or indirectly from the possession, publication, use of, or reliance on information obtained from this report. It is provided in good faith without express or implied warranty. Reference to any specific commercial product or service does not imply endorsement or recommendation by the publisher. All articles are peer-reviewed and protected from any commercial influence. © MD Conference Express®. All rights reserved. Neither this publication nor any part of it may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without the prior written permission of The Goodwin Group International, LLC. MD Conference Express is a registered trademark of The Goodwin Group International, LLC. ISSN 1559-8977 ISSN 2155-756X  http://www.mdconferencexpress.com http://my.americanheart.org/professional/Sessions/ScientificSessions/Scientific-Sessions_UCM_316900_SubHomePage.jsp http://www.scientificsessions.org http://my.americanheart.org http://www.goodwingroupintl.com http://www.facebook.com/mdconferencexpress http://visitor.r20.constantcontact.com/manage/optin/ea?v=001BdwJNcIEVTgv4LtUJBUDeg%3D%3D http://www.mdconferencexpress.com http://www.goodwingroupintl.com

Table of Contents for the Digital Edition of MD Conference Express AHA 2011

MD Conference Express AHA 2011

https://www.nxtbook.com/nxtbooks/md_conference_express/aha2011
https://www.nxtbookmedia.com